Scientech Research’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Scientech Research's NVS Position: Q2 2026 in Review
Scientech Research opened a new position in Novartis (NVS) in Q2 2026: 1,315 shares worth $206K. The stake represents 0.17% of the portfolio and ranks #158 among its holdings. This is a return to the name: Scientech Research previously reported a position in NVS as recently as Q2 2025.
Scientech Research first reported a position in NVS in Q2 2025 and has held it in 2 quarters since. The position peaked at $553K in Q2 2025. 1,631 funds tracked by Wall St. Rank hold NVS as of Q2 2026.
- Scientech Research held 1,315 shares of Novartis worth $206K as of Q2 2026.
- Novartis was a new Scientech Research position in Q2 2026.
- Novartis made up 0.17% of Scientech Research's portfolio in Q2 2026, its #158 holding.
- Scientech Research first reported a position in Novartis in Q2 2025 and has held it in 2 quarters since.
- Scientech Research's Novartis position peaked at $553K in Q2 2025.
- 1,631 funds tracked by Wall St. Rank held Novartis as of Q2 2026.
Based on Scientech Research's 13F filing for Q2 2026, filed 14 Aug 2026.